Emyria Ltd
ASX:EMD
Prices of ASX stocks are not being updated. The latest EMD price on Alpha Spread is from Oct 14, 2026. Financials, forecasts and intrinsic value keep updating.
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Emyria Ltd
ASX:EMD
|
AU |
|
V
|
Vinacomin Viet Bac Mining Industry Holding Corp
VN:MVB
|
VN |
|
L
|
Lindbergh SpA
MIL:LDB
|
IT |
|
B
|
Bim Son Cement JSC
VN:BCC
|
VN |
|
Kwikclick Inc
OTC:KWIK
|
US |
|
S
|
SSE PLC
DUS:SCT
|
UK |
|
SSE PLC
F:SCTA
|
UK |
|
Honda Motor Co Ltd
F:HDMA
|
JP |
|
I
|
Infratil Ltd
ASX:IFT
|
NZ |
|
S
|
SSE PLC
XMUN:SCT
|
UK |
Intrinsic Value
Is EMD undervalued or overvalued?
See the intrinsic value estimate for Emyria Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
EMD looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with EMD’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Emyria Does
Emyria is an Australian healthcare company focused on mental health treatment and drug development. It runs specialist clinics and treatment programs for patients with complex mental health conditions, and it also works on new therapies such as psychedelic-assisted psychotherapy through clinical research and regulated treatment pathways.
- Headquarters
- Australia AU
- IPO date
- Feb 12, 2020
Earnings Waterfall
Emyria Ltd
The intrinsic value for Emyria Ltd (EMD) under the Base Case is hidden AUD.
Compared with the last price of 0.04 AUD on Oct 14, the stock appears hidden.